Actively Recruiting
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Led by The University of Hong Kong · Updated on 2025-06-25
280
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
L
Laboratory of Data Discovery for Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to develop and evaluate a conversational AI pharmacy chatbot to assist patients and caregivers in Hong Kong with questions about medications prescribed by the Hospital Authority (HA). The study focuses on patients with hyperglycaemia, hypertension, or hyperlipidaemia and assesses how well the chatbot answers medication-related questions, its impact on medication adherence, knowledge, and consultation time with pharmacists. Participants will be randomly assigned to one of two groups: an intervention group that uses the AI pharmacy chatbot through WhatsApp for 7 days, and a control group that does not use the chatbot. The chatbot provides instant, pharmacist-validated responses based on HA drug data and targets chronic conditions common in Hong Kong. The study includes a prototype phase with pharmacist feedback and a main phase involving at least 280 patients or caregivers. During the study, participants complete surveys before and after the intervention period, including usability questionnaires for the intervention group. Researchers will evaluate patient satisfaction, medication knowledge, adherence, response times, and pharmacist consultation duration. The study uses mixed qualitative and quantitative methods and runs from June 2025 through October 2026.
CONDITIONS
Brief Title
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older diagnosed with hyperglycaemia, hypertension, or hyperlipidaemia and currently on Hospital Authority-prescribed medication
- Caregivers aged 18 years or older for such patients
You will not qualify if you...
- No specific exclusion criteria; participants must meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for consent and pre-study survey
Duration - 7 days
Participants in the intervention group use the AI pharmacy chatbot through WhatsApp to ask questions related to their prescribed medications for 7 days. The control group does not use the chatbot during this period.
1 baseline visit and 1 follow-up visit (post-study survey)
Trial Site Locations
Total: 2 locations
1
Laboratory of Data Discovery for Health
Hong Kong, Hong Kong
Actively Recruiting
2
The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
J
Joseph Wu, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here